SCHEMBL8175282

SCHEMBL8175282

COC(=O)c1c(-c2ccc(Cl)cc2)c(-c2ccc(S(N)(=O)=O)cc2)nn1Cc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CA12 O43570 9/20 0.53
CA9 Q16790 9/20 0.53
CA1 P00915 8/20 0.53
CA2 P00918 8/20 0.53
PTGS2 P35354 3/20 0.51
PTGS1 P23219 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.50
HTR1A P08908 1/20 0.44
HTR2A P28223 1/20 0.44
HTR7 P34969 1/20 0.44
MAPK8 P45983 1/20 0.44
CHRNA7 P36544 2/20 0.43
MAPK9 P45984 1/20 0.43
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8174283 0.92 CA9 (0.51) CA12CA9CA1CA2PTGS2
SCHEMBL8176221 0.92 CA12 (0.53) CA12CA9CA1CA2PTGS2
SCHEMBL8630923 0.91 MAPK8 (0.54) CA12CA9CA1CA2PTGS2
SCHEMBL7777766 0.89 HTR7 (0.48) CA12CA9CA1CA2PTGS2
SCHEMBL8175330 0.88 CA1 (0.57) CA12CA9CA1CA2PTGS2
SCHEMBL7780610 0.85 MAPK9 (0.54) CA12CA9CA1CA2PTGS2
SCHEMBL8181613 0.85 PTGS2 (0.51) CA12CA9CA1CA2PTGS2
SCHEMBL8174319 0.84 CA1 (0.53) CA12CA9CA1CA2PTGS2
SCHEMBL8173979 0.84 CA1 (0.53) CA12CA9CA1CA2PTGS2
SCHEMBL7780584 0.83 PTGS2 (0.48) CA12CA9CA1CA2PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5756530-A NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G. D. SEARLE & CO. (US) 1998-05-26 US disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed